About this Research Topic
This Research Topic aims to provide an updated clinical and mechanism overview of metabolic disorders effects on pulmonary function, injury, immune response, and regeneration. We welcome authors to contribute original research articles as well as review articles that focus on the topic of Diabetes and Obesity Effects on Pulmonary Function.
Potential sub-topics include, but are not limited to:
- The clinical study of pulmonary disorders (e.g. Fibrosis, COPD, Asthma) in diabetic and obese patients;
- Molecular and cellular mechanisms (e.g., Inflammation, Oxidative Stress) regulating pulmonary function in metabolic disorders;
- Immune response (infection) affected by metabolic disorders in the lung; and
- Effects of metabolic disorders on lung injury, repair, and regeneration.
Conflict of Interests Statement:
The Topic Editor Albert Lecube joined an Investigator Sponsored Study (ISS) from Novo Nordisk related with the potential effects of liraglutide on lung function and sleep breathing in type 2 diabetes: "MULTICENTRE, RANDOMISED, DOUBLE-BLIND, CROSS-OVER PLACEBO-CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF LIRAGLUTIDE ON LUNG FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (LIRALUNG)". ClinicalTrials.gov: NCT02889510
Keywords: Diabetes, Obesity, Injury, Repair, Inflammation, Oxidative Stress, Immune Response, Pulmonary Disease, Pulmonary Fibrosis, PAH, COPD, Asthma
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.